Four new shipments of Covid-19 vaccines arrived in Iran, bringing the total volume of imports to 154.98 million doses, Rouhollah Latifi, spokesman of the Islamic Republic of Iran Customs Administration said on Jan. 19.
The new shipments included 193,000 doses of AstraZeneca from Greece in addition to 70,000 doses of the same vaccine imported from Japan in recent days, he was quoted as saying by IRNA, adding that 2.2 million doses of AstraZeneca donated by Spain arrived on Wednesday morning.
“The total volume of imported AstraZeneca vaccines has reached 15.75 million doses, while the total volume of imported Sinopharm vaccines stands at 134 million doses, Sputnik V at 4.09 million and Bharat at 1.13 million doses,” Latifi said.
The Red Crescent Society of Islamic Republic of Iran is the major importer of the jabs.
Monthly Covid-19 vaccine imports set a record after more than 60 million doses entered Iran in the seventh month of the current fiscal year (Sept. 23-Oct. 22).
The total value of all Covid-19 vaccines imported to Iran from Feb. 3 to Sept. 12 stood at $421 million.
According to IRICA, each Sinopharm vaccine made in China costs $9.2, AstraZeneca made in China $4, AstraZeneca made in Japan $4, COVAX made in Italy $4, Sputnik V made in Russia $10, AstraZeneca made in Russia $6.5, COVAX made in South Korea $4 and AstraZeneca made in Austria $4 and Bharat [COVAXIN] made in India $14.5,” he said.
New figures released by the Health Ministry indicate that nearly 126 million doses of coronavirus vaccines have been administered in the country as of Sunday, with over 60.32 million people having received the first dose, more than 53.13 million fully vaccinated and 12,521,856 adults getting the third dose.